Integer Holdings Corp (ITGR) Director Sells $692,865.00 in Stock

Share on StockTwits

Integer Holdings Corp (NYSE:ITGR) Director Bill R. Sanford sold 8,650 shares of the stock in a transaction on Wednesday, September 5th. The stock was sold at an average price of $80.10, for a total value of $692,865.00. Following the transaction, the director now owns 74,502 shares of the company’s stock, valued at $5,967,610.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Integer stock traded up $0.05 during mid-day trading on Friday, hitting $81.00. 265,015 shares of the company were exchanged, compared to its average volume of 223,461. The company has a debt-to-equity ratio of 1.64, a current ratio of 3.80 and a quick ratio of 2.95. Integer Holdings Corp has a 1-year low of $42.50 and a 1-year high of $82.25. The firm has a market capitalization of $2.59 billion, a P/E ratio of 28.83 and a beta of 0.83.

Integer (NYSE:ITGR) last announced its earnings results on Thursday, August 2nd. The medical equipment provider reported $1.06 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.88 by $0.18. Integer had a return on equity of 12.60% and a net margin of 6.63%. The company had revenue of $313.00 million during the quarter, compared to analyst estimates of $379.41 million. During the same period last year, the company posted $0.62 earnings per share. The firm’s quarterly revenue was up 11.4% compared to the same quarter last year. equities research analysts predict that Integer Holdings Corp will post 3.57 EPS for the current fiscal year.

Hedge funds have recently made changes to their positions in the stock. ClariVest Asset Management LLC increased its position in Integer by 62.6% in the second quarter. ClariVest Asset Management LLC now owns 74,950 shares of the medical equipment provider’s stock worth $4,846,000 after purchasing an additional 28,855 shares during the period. Zions Bancorporation bought a new position in Integer during the second quarter worth about $234,000. GSA Capital Partners LLP boosted its holdings in Integer by 90.5% during the second quarter. GSA Capital Partners LLP now owns 32,463 shares of the medical equipment provider’s stock worth $2,099,000 after buying an additional 15,421 shares during the last quarter. Convergence Investment Partners LLC lifted its holdings in shares of Integer by 205.9% during the 2nd quarter. Convergence Investment Partners LLC now owns 79,683 shares of the medical equipment provider’s stock valued at $5,152,000 after purchasing an additional 53,638 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its holdings in shares of Integer by 15.9% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 40,248 shares of the medical equipment provider’s stock valued at $2,602,000 after purchasing an additional 5,513 shares in the last quarter. Hedge funds and other institutional investors own 96.18% of the company’s stock.

Several research firms have issued reports on ITGR. Northcoast Research upgraded Integer to a “buy” rating and set a $83.00 price objective for the company in a research note on Friday, July 20th. Zacks Investment Research lowered Integer from a “buy” rating to a “hold” rating in a research note on Tuesday, June 19th. ValuEngine lowered Integer from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 12th. TheStreet upgraded Integer from a “c+” rating to a “b” rating in a research note on Monday, August 6th. Finally, KeyCorp reiterated an “overweight” rating and set a $78.00 price objective (up from $65.00) on shares of Integer in a research note on Friday, July 6th. They noted that the move was a valuation call. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $76.80.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates through two segments, Medical and Non-Medical. The company offers arthroscopic devices and components, such as shaver blades and burrs, ablation probes, and suture anchors; laparoscopic and general surgery products, including trocars, endoscopes and laparoscopes, closure devices, harmonic scalpels, bipolar energy delivery devices, radio frequency probes, thermal tumor ablation devices, and ophthalmic surgery devices; and biopsy and drug delivery products.

Read More: Return on Investment (ROI) Defined, Explained

Insider Buying and Selling by Quarter for Integer (NYSE:ITGR)

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply